FDA says yes to NeoGuide anti-looping colonoscopy
This article was originally published in Clinica
NeoGuide Systems has received US market go-ahead for a computer-assisted colonoscopy system that it says is designed to address the major limitations of colonoscopy.
You may also be interested in...
The IVDR implementation schedule is problematic. European notified bodies say solutions must be grasped if public health is not to suffer.
Amid several new and updated draft guidance documents and the potential approach of the first approval, interchangeability continues to be a buzzword in US biosimilars. AbbVie has projected that two Humira (adalimumab) biosimilars will hold the designation when they launch in 2023.
Those marketing products covered under the EU’s MDR and IVD Regulations have plenty of reading this month to help them prepare. More details have also emerged about the UK’s regulatory future.